Home 2019 – EN AI to diagnose invisible brain abnormalities in people with epilepsy Scientists have developed an AI-powered tool that detects 64% of brain abnormalities linked to epilepsy that human radiologists miss. originally Physicist develops algorithm capable of assisting in Parkinson's treatment The research was supervised by CEPID BRAINN´s researchers, Dr. Rickson Mesquita and Dr. Gabriela Castellano. Check out the report from World Health Organization's (WHO) Technical Advisory Group on Genomics (TAG-G), chaired by researcher Iscia Lopes-Cendes, publishes article in Nature Medicine. Article from Agência FAPESP interviews researcher from CEPID BRAINN and details the need for awareness, professional training, and investment in Global Study Identifies Markers for the Five Clinical Stages of Parkinson's Disease Research, which included the participation of BRAINN, analyzed data from over 2,500 individuals with Parkinson's and developed metrics for each 10 years of BRAINN Congress: details on the 2024 edition The CEPID BRAINN Congress celebrates a decade in 2024. Check out details of the event, student participation, and awards. World’s largest epilepsy study reveals ‘genetic architecture’ and points to new therapies Considered the largest genetic study of epilepsy in the world, paper published in Nature Genetics reveals alterations in DNA that 10th BRAINN Congress - a decade of interaction among neuroscience researchers With the presence of national and international researchers specialized in neuroscience, the 10th BRAINN CEPID Congress takes place in early INES 2023 brings together international specialists in Campinas The INES 2023 event gathered researchers from different countries in Campinas for training in neuropathology and neuroimaging, aiming at the 1 2 3 … 7 Next » Post navigation← Dia da Epilepsia 2019Notícias sobre AVC →